Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-25-000648
Filing Date
2025-08-18
Accepted
2025-08-18 18:02:39
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 29087
2 AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D exh1.htm EX-1 37027
3 SCHEDULE A: TRANSACTIONS DURING THE PAST 60 DAYS exh2.htm EX-2 23442
4 POWER OF ATTORNEY REGARDING FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934, A exh3.htm EX-3 27084
5 POWER OF ATTORNEY ON BEHALF OF LIZA LANDSMAN REGARDING FILINGS UNDER THE SECURIT exh4.htm EX-4 6086
  Complete submission text file 0001072613-25-000648.txt   124573
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Subject) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90376 | Film No.: 251229100
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities 18 VGE, LLC (Filed by) CIK: 0001917895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A